Skip to main content
. Author manuscript; available in PMC: 2018 May 2.
Published in final edited form as: Curr Protoc Toxicol. 2017 May 2;72:14.17.1–14.17.23. doi: 10.1002/cptx.23

Table 1. Compounds that have been used for in vitro CYP450 profiling studies in micropatterned cocultures (MPCCs).

All substrates can be reconstituted in dimethyl sulfoxide (DMSO) and incubated in MPCCs at the indicated concentrations for 1 hour. The supernatants are then collected and stored at -80°C prior to LC-MS/MS analysis or luminescence analysis (for the CYP2C9-Glo and CYP3A4-Glo substrates from Promega).

Enzyme Concentration (μM) Substrate Metabolites
1A2 100 Phenacetin Acetaminophen
2A6 50 Coumarin 7-OH-coumarin
2B6 500 Bupropion OH-bupropion
2C8 30 Paclitaxel 6a-OH-paclitaxel
2C9 50 Tolbutamide 4-OH-tolbutamide
2C9 100 Diclofenac 4-OH-diclofenac
2C9 100 CYP2C9-Glo Luciferin
2C19 100 S-mephenytoin 4-OH-S-mephenytoin
2D6 16 Dextromethorphan Dextrorphan
2E1 300 Chlorzoxazone 6-OH-chlorzoxazone
3A4 200 Testosterone 6b-OH-testosterone
3A4 3 CYP3A4-Glo (luciferin-IPA) Luciferin
Phase II Metabolism 50 7-OH-coumarin 7-OH-coumarin glucuronide and 7-OH-coumarin sulfate